FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1638986145> ?p ?o ?g. }

• W1638986145 abstract "Liver transplantation has become a widely accepted form of treatment for numerous end-stage liver diseases. Bile acids may decrease allograft rejection after liver transplantation by changing the expression of major histocompatibility complex class molecules in bile duct epithelium and central vein endothelium.To assess the beneficial and harmful effects of bile acids for liver-transplanted patients.We performed searches of The Cochrane Hepato-Biliary Group Controlled Trials Register, The Cochrane Central Register of Controlled Trials in The Cochrane Library, MEDLINE, EMBASE, and Science Citation Expanded to September, 2009.Randomised clinical trials comparing any dose of bile acids or duration of treatment in liver-transplanted patients versus placebo, no intervention, or another intervention. We included randomised clinical trials irrespective of blinding, language, and publication status.Two review authors extracted and checked data independently. We evaluated the risk of bias of the trials from the method of allocation sequence generation, allocation concealment, blinding, outcome data analysis, outcome data reporting, and other potential sources of bias. We used the intention-to-treat principle to perform meta-analyses and presented the outcomes as relative risks (RR) or mean differences (MD), both with 95% confidence intervals (CI).The updated search resulted in no new trials meeting the inclusion criteria of this review, thus leaving it to the seven already included randomised trials (six evaluating ursodeoxycholic acid versus placebo or no intervention, and one evaluating tauro-ursodeoxycholic acid versus no intervention) enrolling a total of 335 participants. The administration of bile acids began one day or more after liver transplantation. All patients received the standard triple-drug immunosuppressive regimen (steroids, azathioprine, and cyclosporine or tacrolimus) to suppress the allograft rejection response after liver transplantation. Bile acids compared with placebo or no intervention did not significantly change all-cause mortality (RR 0.85, 95% CI 0.53 to 1.36), mortality related to allograft rejection (RR 0.30, 95% CI 0.01 to 7.12), retransplantation (RR 0.76, 95% CI 0.20 to 2.86), acute cellular rejection, or number of patients with steroid-resistant rejection. Bile acids significantly reduced the number of patients who had chronic rejection in a fixed-effect model but not in a random-effects model meta-analysis. Bile acids were safe and well tolerated by liver-transplanted patients. However, this observation is based on data analysis from three trials with only 187 patients.We did not find evidence to support or refute bile acids for liver-transplanted patients. Further randomised trials are necessary before bile acids can be recommended to liver-transplanted patients." @default.
• W1638986145 created "2016-06-24" @default.
• W1638986145 creator A5019275846 @default.
• W1638986145 creator A5065599900 @default.
• W1638986145 creator A5073414305 @default.
• W1638986145 creator A5089038632 @default.
• W1638986145 date "2010-03-17" @default.
• W1638986145 modified "2023-09-28" @default.
• W1638986145 title "Bile acids for liver-transplanted patients" @default.
• W1638986145 cites W1505564792 @default.
• W1638986145 cites W1598602811 @default.
• W1638986145 cites W1909502687 @default.
• W1638986145 cites W1922978848 @default.
• W1638986145 cites W1963553743 @default.
• W1638986145 cites W1964489041 @default.
• W1638986145 cites W1971441597 @default.
• W1638986145 cites W1977231265 @default.
• W1638986145 cites W1978376870 @default.
• W1638986145 cites W1983247609 @default.
• W1638986145 cites W1986035663 @default.
• W1638986145 cites W1987308096 @default.
• W1638986145 cites W1996470340 @default.
• W1638986145 cites W2003280538 @default.
• W1638986145 cites W2010688244 @default.
• W1638986145 cites W2013605037 @default.
• W1638986145 cites W2022177896 @default.
• W1638986145 cites W2022695716 @default.
• W1638986145 cites W2023598977 @default.
• W1638986145 cites W2036433609 @default.
• W1638986145 cites W2038197492 @default.
• W1638986145 cites W2040962527 @default.
• W1638986145 cites W2044576969 @default.
• W1638986145 cites W2047671349 @default.
• W1638986145 cites W2049852456 @default.
• W1638986145 cites W2049950882 @default.
• W1638986145 cites W2060163794 @default.
• W1638986145 cites W2079486977 @default.
• W1638986145 cites W2080521840 @default.
• W1638986145 cites W2084674811 @default.
• W1638986145 cites W2086148792 @default.
• W1638986145 cites W2086975992 @default.
• W1638986145 cites W2087470352 @default.
• W1638986145 cites W2088629497 @default.
• W1638986145 cites W2102696978 @default.
• W1638986145 cites W2107328434 @default.
• W1638986145 cites W2110970000 @default.
• W1638986145 cites W2117294447 @default.
• W1638986145 cites W2124260053 @default.
• W1638986145 cites W2127746188 @default.
• W1638986145 cites W2130883114 @default.
• W1638986145 cites W2134338262 @default.
• W1638986145 cites W2138188443 @default.
• W1638986145 cites W2144512218 @default.
• W1638986145 cites W2146656966 @default.
• W1638986145 cites W2157823046 @default.
• W1638986145 cites W2159175545 @default.
• W1638986145 cites W2160795579 @default.
• W1638986145 cites W2415242393 @default.
• W1638986145 cites W4205363739 @default.
• W1638986145 cites W4210990642 @default.
• W1638986145 cites W4214559180 @default.
• W1638986145 cites W4234343640 @default.
• W1638986145 cites W4234978744 @default.
• W1638986145 cites W4237645899 @default.
• W1638986145 cites W4240657114 @default.
• W1638986145 cites W4240699401 @default.
• W1638986145 cites W4242589154 @default.
• W1638986145 cites W4246654869 @default.
• W1638986145 doi "https://doi.org/10.1002/14651858.cd005442.pub2" @default.
• W1638986145 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20238339" @default.
• W1638986145 hasPublicationYear "2010" @default.
• W1638986145 type Work @default.
• W1638986145 sameAs 1638986145 @default.
• W1638986145 citedByCount "7" @default.
• W1638986145 countsByYear W16389861452012 @default.
• W1638986145 countsByYear W16389861452014 @default.
• W1638986145 countsByYear W16389861452015 @default.
• W1638986145 countsByYear W16389861452016 @default.
• W1638986145 crossrefType "journal-article" @default.
• W1638986145 hasAuthorship W1638986145A5019275846 @default.
• W1638986145 hasAuthorship W1638986145A5065599900 @default.
• W1638986145 hasAuthorship W1638986145A5073414305 @default.
• W1638986145 hasAuthorship W1638986145A5089038632 @default.
• W1638986145 hasConcept C126322002 @default.
• W1638986145 hasConcept C142724271 @default.
• W1638986145 hasConcept C168563851 @default.
• W1638986145 hasConcept C204787440 @default.
• W1638986145 hasConcept C27081682 @default.
• W1638986145 hasConcept C2771230 @default.
• W1638986145 hasConcept C2776478404 @default.
• W1638986145 hasConcept C2779609443 @default.
• W1638986145 hasConcept C2780965833 @default.
• W1638986145 hasConcept C2911091166 @default.
• W1638986145 hasConcept C44249647 @default.
• W1638986145 hasConcept C535046627 @default.
• W1638986145 hasConcept C71924100 @default.
• W1638986145 hasConcept C82789193 @default.
• W1638986145 hasConcept C95190672 @default.
• W1638986145 hasConceptScore W1638986145C126322002 @default.
• W1638986145 hasConceptScore W1638986145C142724271 @default.

• next